Announcements Trials

Browse Landscape

Phase

Status

Completed 19 Unknown 11 Recruiting 7 Terminated 3 Withdrawn 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Anxiety Disorders 2 Unresectable Metastatic Colorectal Cancer 1 Spinal Stenosis 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Intervertebral Disc Displacement 1 Gastrointestinal Stromal Tumors 1 Depression 1 Communication 1 Cervical Cancer Screening 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Trastuzumab 16 pertuzumab 14 Capecitabine 14 Letrozole 12 Docetaxel 12 Cyclophosphamide 12 pyrotinib 11 Paclitaxel 10 Standard of Care 9 Radiotherapy 9 Carboplatin 9 trastuzumab deruxtecan 8 Fulvestrant 8 Drug Therapy 8 sacituzumab govitecan 7 Anastrozole 7 exemestane 6 eribulin 6 dalpiciclib 6 abemaciclib 6 Tamoxifen 6 Epirubicin 6 pembrolizumab 5 palbociclib 5 Neoadjuvant Therapy 5 camrelizumab 4 Surveys and Questionnaires 4 Sentinel Lymph Node Biopsy 4 Magnetic Resonance Spectroscopy 4 Fluorodeoxyglucose F18 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Breast Neoplasms × Control Groups × Clear all

NCT07042737 2025-06-29

Menopause

Inonu University

Phase NA Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡